CLINICAL_TRIALS
trial_result
· 2026-03-13
Clinical Trial Update: A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris [Phase 1]
Summary
A Phase 1 study comparing Tretinoin Gel Microsphere 0.04% and Retin-A Micro Gel Microsphere 0.04% for acne vulgaris has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED